Nyxoah SA - Ordinary Shares (OQ:NYXH)
Business Focus: N/A
Apr 11, 2024 04:30 pm ET
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer Mont-Saint-Guibert, Belgium – April 11, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused...
Mar 29, 2024 04:30 pm ET
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), March 29, 2024, 9:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...
Mar 25, 2024 02:05 am ET
Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation
Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery FoundationFirst medical device company to become a corporate champion at the ENTerprise Circle level...
Mar 19, 2024 04:05 pm ET
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints Reports an Apnea-Hypopnea Index (AHI) responder rate of 63.5% on an intent to treat (ITT) basis (p=0.002)Reports an Oxygen Desaturation Index (ODI) responder rate of 71.3% on an...
Mar 05, 2024 04:05 pm ET
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating ResultsExpect to report DREAM U.S. pivotal study efficacy and safety data by early AprilAchieved record quarterly sales of €1.8 million Mont-Saint-Guibert, Belgium –...
Feb 29, 2024 04:30 pm ET
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgium – February 29, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a...
Feb 15, 2024 04:30 pm ET
Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024
Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024 Mont-Saint-Guibert, Belgium – February 15, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical...
Jan 31, 2024 08:31 am ET
Thinking about buying stock in Guardion Health Sciences, Minim, Revelation Biosciences, Nyxoah, or Pixelworks?
NEW YORK, Jan. 31, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GHSI, MINM, REVB, NYXH, and PXLW.
Jan 24, 2024 08:31 am ET
Thinking about buying stock in NXU Inc., Alibaba, AT&T, BlackBerry, or Nyxoah?
NEW YORK, Jan. 24, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NXU, BABA, T, BB, and NYXH.
Jan 17, 2024 04:05 pm ET
Nyxoah Announces 2024 Strategic Priorities
Nyxoah Announces 2024 Strategic Priorities Mont-Saint-Guibert, Belgium – January 17, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and...
Jan 09, 2024 04:05 pm ET
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023 Mont-Saint-Guibert, Belgium – January 9, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology...
Dec 11, 2023 01:30 am ET
Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®
Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio® Data presented at the DGSM Conference in Berlin by Dr. Christian Plettenberg on December 8, 2023Results showed an average AHI decrease of...
Dec 08, 2023 04:30 pm ET
Publication Relating to a Transparency Notification
REGULATED INFORMATION Publication Relating to a Transparency Notification Mont-Saint-Guibert (Belgium), December 8, 2023, 10.30pm CET / 4.30pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large...
Nov 28, 2023 04:30 pm ET
Nyxoah Strengthens its Executive Leadership Team
Nyxoah Strengthens its Executive Leadership TeamFrancis Kim appointed as Chief Regulatory and Quality Officer Mont-Saint-Guibert, Belgium – November 28, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the...
Nov 21, 2023 04:30 pm ET
Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference
Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – November 21, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology...
Nov 08, 2023 04:05 pm ET
Nyxoah Reports Third Quarter 2023 Financial and Operating Results
Nyxoah Reports Third Quarter 2023 Financial and Operating ResultsPartners with ResMed Germany to increase OSA awareness and therapy penetration Mont-Saint-Guibert, Belgium – November 8, 2023 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext...
Nov 07, 2023 04:30 pm ET
Nyxoah to Participate in the Jefferies London Healthcare Conference
Nyxoah to Participate in the Jefferies London Healthcare Conference Mont-Saint-Guibert, Belgium – November 7, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company...
Oct 26, 2023 04:30 pm ET
Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023
Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023 Mont-Saint-Guibert, Belgium – October 26, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology...
Sep 28, 2023 04:30 pm ET
Nyxoah Announces Partnership with ResMed in Germany
Nyxoah Announces Partnership with ResMed in GermanyCreates a continuum of care in the German obstructive sleep apnea market Mont-Saint-Guibert, Belgium – September 28, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)...
Sep 12, 2023 04:30 pm ET
Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference
Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference Mont-Saint-Guibert, Belgium – September 12, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology...
Sep 05, 2023 04:30 pm ET
Nyxoah to Participate in Upcoming Investor Conferences
Nyxoah to Participate in Upcoming Investor Conferences Mont-Saint-Guibert, Belgium – September 5, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the...
Aug 30, 2023 04:30 pm ET
Information on the Total Number of Voting Rights and Shares
REGULATED INFORMATION Information on the Total Number of Voting Rights and Shares Mont-Saint-Guibert (Belgium), August 30, 2023, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...
Aug 08, 2023 04:05 pm ET
Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results
REGULATED INFORMATION Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results Mont-Saint-Guibert, Belgium – August 8, 2023 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the...
Jul 27, 2023 04:30 pm ET
Information on the Total Number of Voting Rights and Shares
REGULATED INFORMATION Information on the Total Number of Voting Rights and Shares Mont-Saint-Guibert (Belgium), July 27, 2023, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...
Jul 27, 2023 04:30 pm ET
Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference
Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference Mont-Saint-Guibert, Belgium – July 27, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company...
Jul 27, 2023 04:30 pm ET
Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023
Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023 Mont-Saint-Guibert, Belgium – July 27, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company...
Jul 27, 2023 04:30 pm ET
Publication Relating to a Transparency Notification
REGULATED INFORMATION Publication Relating to a Transparency Notification Mont-Saint-Guibert (Belgium), July 27, 2023, 10.30pm CET / 4.30pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large...
May 16, 2023 04:05 pm ET
Nyxoah Reports First Quarter 2023 Financial and Operating Results
REGULATED INFORMATION Nyxoah Reports First Quarter 2023 Financial and Operating Results Mont-Saint-Guibert, Belgium – May 16, 2023 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical...
May 12, 2023 01:00 am ET
Invitation to Attend the Annual Shareholders’ Meeting of the Company to be Held on June 14, 2023
REGULATED INFORMATIONMay 12, 2023, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH)Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the “Company”) Invitation to Attend the Annual Shareholders’ Meeting of the Company to...
May 10, 2023 04:05 pm ET
Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer
Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer Mont-Saint-Guibert, Belgium – May 10, 2023, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on...
May 01, 2023 04:30 pm ET
Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023
Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023 Mont-Saint-Guibert, Belgium – May 1, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused...
Apr 20, 2023 04:30 pm ET
Publication Relating to Transparency Notifications
REGULATED INFOMATION Publication Relating to Transparency Notifications Mont-Saint-Guibert (Belgium), April 20, 2023, 10.30pm CET / 4.30pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large...
Apr 17, 2023 04:30 pm ET
Information on the Total Number of Voting Rights and Shares
REGULATED INFORMATION Information on the Total Number of Voting Rights and Shares Mont-Saint-Guibert (Belgium), April 17, 2023, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...
Apr 13, 2023 04:05 pm ET
Nyxoah Raises $3 Million from its At-the-Market Equity Offering
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Raises $3 Million from its At-the-Market Equity Offering Mont-Saint-Guibert, Belgium – April 13, 2023, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the...
Mar 31, 2023 04:30 pm ET
Information on the Total Number of Voting Rights and Shares
REGULATED INFORMATION Information on the Total Number of Voting Rights and Shares Mont-Saint-Guibert (Belgium), March 31, 2023, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...
Mar 27, 2023 04:05 pm ET
Nyxoah Raises $3 Million from an At-the-Market Equity Offering
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Raises $3 Million from an At-the-Market Equity Offering Mont-Saint-Guibert, Belgium – March 27, 2023, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the...
Mar 23, 2023 04:05 pm ET
Nyxoah Announces a $15 Million Private Placement Financing
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces a $15 Million Private Placement Financing Mont-Saint-Guibert, Belgium – March 23, 2023, 9:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the...
Mar 22, 2023 04:05 pm ET
Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
REGULATED INFORMATION Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating ResultsCompleted all 115 implants in the DREAM U.S. pivotal study Mont-Saint-Guibert, Belgium – March 22, 2023 09:05pm CET / 4:05pm ET – Nyxoah SA...
Mar 08, 2023 04:30 pm ET
Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023
Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 Mont-Saint-Guibert, Belgium – March 8, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical...
Mar 07, 2023 04:30 pm ET
Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference
Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference Mont-Saint-Guibert, Belgium – March 7, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology...
Mar 06, 2023 01:30 am ET
Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces Achievement of Key Clinical and Regulatory MilestonesAll 115 patients implanted in DREAM U.S. pivotal studyFirst DREAM PMA module submittedFirst patient implanted in ACCCESS U.S....
Feb 22, 2023 06:00 am ET
Nyxoah Announces Inaugural Investor & Analyst Meeting
Nyxoah Announces Inaugural Investor & Analyst Meeting Mont-Saint-Guibert, Belgium – February 22, 2023, 12:00pm CET / 6:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on...
Feb 21, 2023 04:30 pm ET
Nyxoah Announces Inaugural Investor & Analyst Meeting
Nyxoah Announces Inaugural Investor & Analyst Meeting Mont-Saint-Guibert, Belgium – February 21, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on...
Jan 09, 2023 04:30 pm ET
Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors
Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors Mont-Saint-Guibert, Belgium – January 9, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused...
Dec 29, 2022 04:30 pm ET
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), December 29, 2022, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of...
Dec 22, 2022 04:12 pm ET
Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program Mont-Saint-Guibert, Belgium – December 22, 2022, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq:...
Nov 17, 2022 04:30 pm ET
Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference
Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – November 17, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology...
Nov 08, 2022 04:05 pm ET
Nyxoah Reports Third Quarter 2022 Financial and Operating Results
REGULATED INFORMATION Nyxoah Reports Third Quarter 2022 Financial and Operating Results DREAM US pivotal 12-month clinical data expected in fall of 2023 Mont-Saint-Guibert, Belgium – November 8, 2022, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext...
Oct 24, 2022 04:30 pm ET
Nyxoah Announces Change to Board of Directors
Nyxoah Announces Change to Board of Directors Mont-Saint-Guibert, Belgium – October 24, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the...
Oct 20, 2022 04:30 pm ET
Nyxoah to Participate in the Jefferies London Healthcare Conference
Nyxoah to Participate in the Jefferies London Healthcare Conference Mont-Saint-Guibert, Belgium – October 20, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company...
Oct 18, 2022 04:30 pm ET
Nyxoah to Release Third Quarter Financial Results on November 8, 2022
Nyxoah to Release Third Quarter Financial Results on November 8, 2022 Mont-Saint-Guibert, Belgium – October 18, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company...
Sep 30, 2022 04:30 pm ET
Information on the total number of voting rights and shares
REGULATED INFORMATION Mont-Saint-Guibert (Belgium), September 30, 2022, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH)...
Aug 18, 2022 04:30 pm ET
Nyxoah to Participate in the 17th Annual Wells Fargo Securities Healthcare Conference
Nyxoah to Participate in the 17th Annual Wells Fargo Securities Healthcare Conference Mont-Saint-Guibert, Belgium – August 18, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical...
Aug 08, 2022 04:05 pm ET
Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results
REGULATED INFORMATION Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results DREAM enrollment complete, 12-month clinical data expected in fall of 2023 Mont-Saint-Guibert, Belgium – August 8, 2022, 10:05pm CET /...
Aug 02, 2022 02:00 am ET
Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test
Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test Mont-Saint-Guibert, Belgium – August 2, 2022, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the...
Jul 27, 2022 04:30 pm ET
Nyxoah to Present at the Canaccord Genuity 42nd Annual Growth Conference
Nyxoah to Present at the Canaccord Genuity 42nd Annual Growth Conference Mont-Saint-Guibert, Belgium – July 27, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology...
Jul 19, 2022 04:30 pm ET
Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022
Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022 Mont-Saint-Guibert, Belgium – July 19, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical...
Jul 18, 2022 04:30 pm ET
Nyxoah Announces CE Mark Approval for Genio® 2.1
Nyxoah Announces CE Mark Approval for Genio® 2.1 The next generation external activation chip leverages Nyxoah’s scalable platform to continuously enhance patient comfort and therapy efficacy Mont-Saint-Guibert, Belgium – July 18, 2022,...
Jul 11, 2022 02:00 am ET
Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio® in Complete Concentric Collapse Patients
REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio® in Complete Concentric Collapse Patients First ACCCESS patient expected to be implanted in Q4 2022 Mont-Saint-Guibert, Belgium –...
Jun 30, 2022 04:30 pm ET
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 30, 2022, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...
Jun 07, 2022 04:30 pm ET
Nyxoah Joins the Euronext Tech Leaders Initiative, Included in the Euronext Tech Leaders Index
Nyxoah Joins the Euronext Tech Leaders Initiative, Included in the Euronext Tech Leaders Index Mont-Saint-Guibert, Belgium – June 7, 2022 4:30pm ET / 10:30pm CET– Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical...
Jun 01, 2022 04:30 pm ET
FDA Approves Genio® 2.1 For Use in DREAM U.S. IDE Pivotal Study
FDA Approves Genio® 2.1 For Use in DREAM U.S. IDE Pivotal Study New smartphone application, upgraded activation chip, improved user interface, and stimulation amplitude trimming enhance patient experience and comfort Mont-Saint-Guibert,...
May 10, 2022 02:55 am ET
Nyxoah Reports First Quarter 2022 Financial and Operating Results
REGULATED INFORMATION Nyxoah Reports First Quarter 2022 Financial and Operating Results Mont-Saint-Guibert, Belgium – May 10, 2022, 08:50pm CET / 2:50pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical...
May 09, 2022 04:30 pm ET
Nyxoah Reports First Quarter 2022 Financial and Operating Results
REGULATED INFORMATION Nyxoah Reports First Quarter 2022 Financial and Operating Results Mont-Saint-Guibert, Belgium – May 9, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical...
May 06, 2022 01:00 am ET
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 8, 2022
REGULATED INFORMATIONMay 6, 2022, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH)Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the “Company”) Invitation to attend the annual and the extraordinary shareholders’...
May 06, 2022 01:00 am ET
Nyxoah Nominates Raymond Cohen and Virginia Kirby for Appointment to Its Board of Directors
Nyxoah Nominates Raymond Cohen and Virginia Kirby for Appointment to Its Board of Directors Mont-Saint-Guibert, Belgium – May 6, 2022, 7:00am CET / 1:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical...
Apr 28, 2022 04:30 pm ET
Nyxoah to Release First Quarter 2022 Financial Results on May 9 and Host Conference Call on May 10, 2022
Nyxoah to Release First Quarter 2022 Financial Results on May 9 and Host Conference Call on May 10, 2022 Mont-Saint-Guibert, Belgium – April 28, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the...
Mar 24, 2022 04:30 pm ET
Nyxoah Reports Full Year 2021 Operating and Financial Results
REGULATED INFORMATION Nyxoah Reports Full Year 2021 Operating and Financial Results Mont-Saint-Guibert, Belgium – March 24, 2022, 9:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical...
Mar 14, 2022 06:30 pm ET
BETTER SLEEP Achieves Primary Endpoint Across All Patient Cohorts
BETTER SLEEP Achieves Primary Endpoint Across All Patient Cohorts First clinical data demonstrating effectiveness of HGNS to treat CCC patients As previously disclosed, confirms achievement of primary endpoint of AHI4 reductions for entire...
Mar 10, 2022 04:30 pm ET
Nyxoah to Participate in the Oppenheimer 32nd Annual Healthcare Conference
Nyxoah to Participate in the Oppenheimer 32nd Annual Healthcare Conference Mont-Saint-Guibert, Belgium – March 10, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company...
Mar 07, 2022 04:30 pm ET
Nyxoah to Present BETTER SLEEP Data, Host Physician Events at World Sleep Congress 2022
Nyxoah to Present BETTER SLEEP Data, Host Physician Events at World Sleep Congress 2022 Mont-Saint-Guibert, Belgium – March 7, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical...
Mar 03, 2022 04:30 pm ET
Nyxoah to Release Full Year 2021 Financial Results on March 24 and Host Conference Call on March 25, 2022
Nyxoah to Release Full Year 2021 Financial Results on March 24 and Host Conference Call on March 25, 2022 Mont-Saint-Guibert, Belgium – March 3, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the...
Feb 11, 2022 04:30 pm ET
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), February 11, 2022, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of...
Feb 04, 2022 04:30 pm ET
Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Mont-Saint-Guibert, Belgium – February 4, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical...
Jan 10, 2022 01:00 am ET
Nyxoah Provides General Corporate Update
Nyxoah Provides General Corporate Update Transformational 2021 positions Nyxoah for further clinical, regulatory, and commercial milestones in 2022 Mont-Saint-Guibert, Belgium – January 10, 2022, 7:00am CET / 1:00am ET –...
Nov 26, 2021 04:30 pm ET
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), November 26, 2021, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...
Nov 12, 2021 04:30 pm ET
Nyxoah Announces Participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference
Nyxoah Announces Participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference Mont-Saint-Guibert, Belgium. – November 12, 2021, 10:30 pm CET / 4:30 pm ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a...
Nov 08, 2021 04:30 pm ET
Nyxoah appoints new CFO
Nyxoah appoints new CFO Mont-Saint-Guibert, Belgium – November 8, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and...
Nov 03, 2021 05:30 pm ET
Nyxoah Announces Participation in the Stifel 2021 Virtual Healthcare Conference
Nyxoah Announces Participation in the Stifel 2021 Virtual Healthcare Conference Mont-Saint-Guibert, Belgium. – November 3, 2021, 10:30 pm CET / 4:30 pm ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical...
Oct 29, 2021 04:30 pm ET
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), October 29, 2021, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...
Oct 04, 2021 04:30 pm ET
Nyxoah Announces CE-Mark Indication Approval to Treat Complete Concentric Collapse (CCC) Patients
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces CE-Mark Indication Approval to Treat Complete Concentric Collapse (CCC) Patients Notified Body DEKRA approves IFU changes to remove warning regarding CCC patients Mont-Saint-Guibert,...
Oct 01, 2021 04:30 pm ET
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), October 1, 2021, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...
Sep 14, 2021 02:00 am ET
Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse Mont-Saint-Guibert (Belgium), September 14, 2021,...
Sep 13, 2021 04:30 pm ET
Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference
Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference Mont-Saint-Guibert (Belgium), September 13, 2021, 10:30 pm CET / 4:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical...
Sep 12, 2021 04:30 pm ET
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), September 12, 2021, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...
Sep 02, 2021 04:30 pm ET
Nyxoah Announces Participation in the Baird 2021 Global Healthcare Conference
PRESS RELEASE Nyxoah Announces Participation in the Baird 2021 Global Healthcare Conference Mont-Saint-Guibert, Belgium – September 2, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical...
Sep 01, 2021 04:30 pm ET
Publication relating to transparency notifications
PRESS RELEASE REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), September 1, 2021, 10.30pm CET / 4.30pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of...
Aug 31, 2021 04:30 pm ET
Nyxoah Issues First Half 2021 Financial Results
REGULATED INFORMATION Nyxoah Issues First Half 2021 Financial Results Mont-Saint-Guibert, Belgium – August 31, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company...
Aug 27, 2021 04:30 pm ET
Nyxoah Appoints Rita Johnson-Mills to its Board of Directors
Nyxoah Appoints Rita Johnson-Mills to its Board of Directors Mont-Saint-Guibert, Belgium – August 27, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company...
Aug 11, 2021 04:30 pm ET
Nyxoah to Release First Half 2021 Financial Results on August 31 and Host Earnings Conference Call on September 1, 2021
Mont-Saint-Guibert, Belgium. - August 11, 2021, 10:30 pm CET / 4:30 pm ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions...
Jul 19, 2021 04:30 pm ET
Publication relating to a transparency notification
PRESS RELEASEREGULATED INFORMATION Publication relating to a transparency notification Mont-Saint-Guibert (Belgium), July 19, 2021, 10.30pm CET / 4.30pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large...
Jul 14, 2021 04:30 pm ET
Publication relating to a transparency notification
PRESS RELEASE REGULATED INFOMATION Publication relating to a transparency notification Mont-Saint-Guibert (Belgium), July 14, 2021, 10:30pm CET / 4:30pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large...
Jul 09, 2021 04:30 pm ET
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), July 9, 2021, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...
Jul 08, 2021 04:30 pm ET
Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters’ Full Exercise of Option to Purchase Additional Shares
REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters’ Full Exercise of Option to Purchase Additional Shares Mont-Saint-Guibert, Belgium – July 8, 2021, 10:30pm CET / 4:30pm ET – Nyxoah...
Jul 07, 2021 04:30 pm ET
Information on the total number of voting rights and shares
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), July 7, 2021, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large...
Jul 02, 2021 08:40 am ET
Nyxoah Announces Pricing of Nasdaq Public Offering
Mont-Saint-Guibert, Belgium – July 2, 2021, 2:40pm CET / 8:40am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to...
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
